A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms.You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
How is the industry evolving?
How is the industry being shaped by new technologies?
How is demand growing in emerging markets and mature economies?
What is the size of the market now and in the future?
What are the financial results of the leading companies?
What are the names and titles of top executives?
What are the top companies and what are their revenues?
Contents, Statistics, Forecasts and Analysis Include:
Major Trends Affecting the Biotech & Genetics Industry
1) The State of the Biotechnology Industry Today 2) A Short History of Biotechnology 3) Ethanol Production Soared, But U.S. Federal Subsidy Expires 4) Cellulosic Ethanol Makes Slow Commercial Progress 5) Major Drug Companies Acquire or Partner With Smaller Biotech Firms 6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development 7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance 8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing 9) Vaccines and Viruses in Drug Delivery 10) New Blockbuster Drugs Come to Market/ Drug Prices Soar 11) Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues 12) Coupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S., Which Are Vastly Higher than Prices Paid in Other Nations 13) Biotech and Orphan Drugs Create New Revenues for Drug Firms 14) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce 15) Stem Cells—Multiple Sources Stem from New Technologies 16) Government Support for Stem Cell Research Evolves 17) Stem Cells—Therapeutic Cloning Techniques Advance 18) Stem Cells—A New Era of Tissue Replacement Takes Shape 19) Nanotechnology Converges with Biotech 20) Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High 21) Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation 22) Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories/3-D Printed Food Appears 23) Selective Breeding, Zinc Fingers, Mutagenesis and Gene-Editing as Alternatives to GMOs 24) Immunotherapy Promises New Approach to Fighting Cancers 25) Technology Discussion—Genes and DN 26) Technology Discussion—Proteins and Proteomics 27) Technology Discussion—DNA Chips 28) Technology Discussion—SNPs (“Snips”) 29) Technology Discussion—Synthetic Biology 30) Technology Discussion—Recombinant DNA 31) Technology Discussion—Polymerase Chain Reaction (PCR)
Biotech & Genetics Industry Statistics
1) Biotech Industry Statistics and Market Size Overview 2) The U.S. Drug Discovery & Approval Process 3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2016 4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2016 5) Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2016 6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2015-2017 7) U.S. Exports & Imports of Pharmaceutical Products: 2011-1st Quarter 2017 8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution 2009-2025 9) Prescription Drug Expenditures, U.S.: Selected Years, 1965-2025 10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2015 11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2016-2018 12) Global Area of Biotech Crops by Country: 2016 13) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2015 14) Sales By Geographic Area, PhRMA Member Companies: 2014 15) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2015 16) Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2014